The routine use of oral steroids in paediatric asthma is not routine

I would like to thank the authors of Physician and parent barriers to the use of oral corticosteroids for the prevention of paediatric URTI-induced acute asthma exacerbations at home, published in the July 2017 issue for their contribution in our efforts to understand and improve translational medicine; their opinions are valuable and welcome. Unfortunately, they have directed their talents to study barriers preventing physicians and parents from adopting a treatment strategy that is controversial at best and widely rejected at worst